🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Portal vein tumor invasion (PVT) is a common complication in HCC. the study...
Status
Completed
Location
Multiple Locations
Start Date
2014-09
Trial ID
NCT03007212
Treatments Being Tested
Objective: This study was conducted to evaluate the effectiveness of music ...
Status
Completed
Location
Inonu University
Start Date
2025-03-15
Trial ID
NCT07425847
Treatments Being Tested
The study aims to assess the beat-to-beat Heart rate variability (HRV) in d...
Status
Recruiting
Location
Alexandria university
Start Date
2023-08-23
Trial ID
NCT06305195
Treatments Being Tested
Epilepsy is a common disease among children. Today, treating epilepsy remai...
Status
Completed
Location
Mashhad University of Medical Sciences
Start Date
2024-12-05
Trial ID
NCT06703983
Treatments Being Tested
This phase II trial compares the impact of brentuximab vedotin and nivoluma...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-12-04
Trial ID
NCT07572123
Treatments Being Tested
M108 is a monoclonal antibody specific for gastric and gastroesophageal ade...
Status
Unknown
Location
Beijing Cancer Hospital
Start Date
2021-06-11
Trial ID
NCT04894825
The researchers will perform a parallel randomized, clinical trial involvin...
Status
Completed
Location
Mansoura University
Start Date
2020-12-01
Trial ID
NCT06647199
Treatments Being Tested
This study is designed to evaluate the effects of Transcutaneous Electrical...
Status
Completed
Location
Yozgat Bozok Univercity
Start Date
2025-08-01
Trial ID
NCT07405502
Treatments Being Tested
The objective of this study was to compare the efficacy of computer-assiste...
Status
Completed
Location
Multiple Locations
Start Date
2008-09-01
Trial ID
NCT04627324
This phase I trial studies the side effects and best dose of autologous CD8...
Status
Withdrawn
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2025-04-15
Trial ID
NCT06094842